MAPT and Cognitive impairment: In this context, we aimed to test the hypothesis that blood LDL-C moderates the association between cerebral Aβ and tau deposition in older adults with a diverse cognitive spectrum including cognitively normal (CN), mild cognitive impairment (MCI), and AD dementia.